Many HCM patients have issues with metoprolol, the beta-blocker most widely prescribed for HCM. There may be multiple reasons for this, but a key one has been known for some time: many generic formulations of metoprolol succinate have time-release mechanisms that do not work in a similar fashion to the brand-name Toprol XL.
The result is that patients receive doses that are not equivalent to what was prescribed. Some develop symptoms as a result.
A new blog post by pharmacologist Joe Graedon on The People’s Pharmacy blog describes the problem well.
The HCMA has been aware of this problem for quite some time. It’s caused by lax oversight of generic drugs by the FDA, especially those manufactured in other countries.
What can HCM patients do? Dr. Lever emphasizes:
You can find useful information in our video library, especially in these interviews:
The post Problems with generic metoprolol appeared first on Hypertrophic Cardiomyopathy Association.